Primary Biliary Cholangitis

Snapshot

  • A 40-year-old woman presents to the urgent care for excessive fatigue and jaundice. She reports that she had felt fatigued for months. Recently, she noticed that her skin is more orange. On physical exam, she is noted to have scleral icterus and jaundice. Laboratory results reveal transaminitis. Anti-smooth muscle antibodies were negative, but a liver biopsy showed granulomatous inflammation of the bile ducts.

Introduction

  • Overview 
    • primary biliary cholangitis (PBC) is a granulomatous autoimmune condition resulting in destruction of the interlobular bile ducts 
      • also known as primary biliary cirrhosis
  • Epidemiology
    • demographics
      • female > male
      • middle-aged (>40 years of age)
    • risk factors
      • family history
  • Pathogenesis
    • autoimmune attack on anti-mitochondrial antigens on biliary epithelial cells
    • autoantibodies
      • anti-mitochondrial antibodies (AMAs)
  • Associated conditions
    • other autoimmune diseases
      • CREST syndrome
      • rheumatoid arthritis
      • celiac disease
      • Hashimoto thyroiditis
  • scleroderma

Presentation

  • Symptoms
    • common symptoms
      • fatigue
      • pruritus 
        • worse at night
        • secondary to bile salts deposited in the skin
      • dark urine
      • light-colored stool
      • right upper quadrant pain
  • Physical exam
    • inspection
      • jaundice
      • hepatosplenomegaly
  • may have xanthomas or xanthelasma

Imaging

  • Ultrasound
    • indication
      • to assess for hepatobiliary disease
    • views
      • right upper quadrant
    • findings
      • cirrhosis, including increased nodularity, atrophy, or hypertrophy
      • distinguish between intra and extrahepatic biliary obstruction
  • ERCP (endoscopic retrograde cholangiopancreatography)
    • indication
      • ultrasound is inconclusive, or concern for gallstones
    • findings
      • extrahepatic ducts appear grossly normal
  • contrast to “string of beads” in primary sclerosing cholangitis

Studies

  • Serum labs  
    • liver function tests showing cholestasis pattern
      • ↑ direct bilirubin
      • ↑ alkaline phosphatase
    • autoantibodies 
      • + anti-mitochondrial antibody (AMA)
        • 90-95% sensitivity
        • > 99% specificity
      • + anti-smooth muscle antibody (ASMA)
        • in 50% of patients
      • + anti-nuclear antibody (ANA)
        • in 50% of patients
    • ↑ IgM
    • ↑ cholesterol
  • Invasive studies
    • liver biopsy 
      • indication
        • in AMA-negative patients in whom clinical suspicion is strong for PBC
      • findings
        • nonsuppurative cholangitis and destruction of interlobular biliary ducts
        • degenerating bile duct with lymphoid structures and granulomas
  • Diagnosis with 2 or more of
    • alkaline phosphatase > 1.5x upper limit of normal for 6 months or more
    • + AMA in serum
  • liver biopsy showing signs of PBC

Differential

  • Hemochromatosis
    • key distinguishing factor
      • triad of cirrhosis, diabetes, and skin bronze pigmentation
  • Wilson disease
    • key distinguishing factors
      • patients typically present before age 40
  • cirrhosis, neurologic disease, psychiatric disease, and Kayser-Fleischer rings in the eyes

Treatment

  • Lifestyle
    • avoidance of alcohol
    • vaccination against hepatitis A and B
  • Medical
    • ursodeoxycholic acid 
      • indications
        • all patients
    • cholestyramine
      • indications
        • pruritus
  • Surgical
    • liver transplantation
      • indications
        • decompensated liver disease
  • severe pruritus refractory to other therapies

Complications

  • Portal hypertension
  • Cirrhosis
  • Osteoporosis
    • monitor with DEXA scan
    • supplement with vitamin D3